The usefulness of CanAssist breast in the assessment of recurrence risk in patients of ethnic Indian origin
Accurate recurrence risk assessment in hormone receptor positive, HER2/neu negative breast cancer is critical to plan precise therapy. CanAssist Breast (CAB) assesses recurrence risk based on tumor biology using artificial intelligence-based approach. We report CAB risk assessment correlating with d...
Main Authors: | Dinesh Chandra Doval, Anurag Mehta, S.P. Somashekhar, Aparna Gunda, Gurpreet Singh, Amanjit Bal, Siddhant Khare, Chandra Prakash V Serkad, Manjula Adinarayan, Naveen Krishnamoorthy, Devanhalli Govinda Vijay, Radha Anantakrishnan, G.S. Bhattacharyya, Manjiri M. Bakre |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-10-01
|
Series: | Breast |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0960977621003799 |
Similar Items
-
The usefulness of CanAssist Breast over Ki67 in breast cancer recurrence risk assessment
by: Mallikarjuna Siraganahalli Eshwaraiah, et al.
Published: (2023-06-01) -
Analytical validation of CanAssist-Breast: an immunohistochemistry based prognostic test for hormone receptor positive breast cancer patients
by: Arun Kumar Attuluri, et al.
Published: (2019-03-01) -
Clinical validation of an immunohistochemistry‐based CanAssist‐Breast test for distant recurrence prediction in hormone receptor‐positive breast cancer patients
by: Manjiri M. Bakre, et al.
Published: (2019-04-01) -
Ten-year distant-recurrence risk prediction in breast cancer by CanAssist Breast (CAB) in Dutch sub-cohort of the randomized TEAM trial
by: Xi Zhang, et al.
Published: (2023-04-01) -
Comparison of breast cancer prognostic tests CanAssist Breast and Oncotype DX
by: Aditya K. Sengupta, et al.
Published: (2020-11-01)